guanethidine has been researched along with dexmedetomidine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Basbaum, AI; Hedley, LR; Hunter, JC; Jasper, JR; Malmberg, AB | 1 |
Adamidis, K; Harkitis, P; Johnson, EO; Konstandi, M; Kostakis, D; Lang, MA; Marselos, M | 1 |
Johnson, EO; Konstandi, M; Kostakis, D; Lang, MA; Marselos, M | 1 |
1 review(s) available for guanethidine and dexmedetomidine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for guanethidine and dexmedetomidine
Article | Year |
---|---|
Contribution of alpha(2) receptor subtypes to nerve injury-induced pain and its regulation by dexmedetomidine.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Analgesics; Animals; Dexmedetomidine; Female; Genotype; Guanethidine; Male; Mice; Pain; Peripheral Nerve Injuries; Point Mutation; Receptors, Adrenergic, alpha-2; Sympathectomy, Chemical; Sympatholytics | 2001 |
Benzo(alpha)pyrene-induced up-regulation of CYP1A2 gene expression: role of adrenoceptor-linked signaling pathways.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Benzo(a)pyrene; Catecholamines; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme System; Cytochromes; Dexmedetomidine; Epinephrine; Gene Expression Regulation, Enzymologic; Guanethidine; Levodopa; Male; Oxidoreductases; Prazosin; Rats; Rats, Wistar; Receptors, Adrenergic; Reserpine; RNA, Messenger; Signal Transduction; Sympatholytics; Up-Regulation | 2006 |
Predominant role of peripheral catecholamines in the stress-induced modulation of CYP1A2 inducibility by benzo(alpha)pyrene.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Benzo(a)pyrene; Catecholamines; Cytochrome P-450 CYP1A2; Dexmedetomidine; Drug Therapy, Combination; Environmental Pollutants; Enzyme Induction; Gene Expression Regulation, Enzymologic; Guanethidine; Imidazoles; Injections, Intraperitoneal; Male; Microsomes, Liver; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Reserpine; Restraint, Physical; Stress, Physiological | 2008 |